Adcirca, a new formulation of tadalafil (Cialis) for treating pulmonary arterial hypertension

Please see the August 2012 FDA warning concerning the use of Revatio in children with PAH

You'll see Adcirca, a new formulation of tadalafil (Cialis) for treating pulmonary arterial hypertension.

It will be used as an alternative to Revatio (sildenafil).

Both Adcirca and Revatio can help improve exercise tolerance in these patients by lowering blood pressure in the lungs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote